Suven Life Sciences Limited (NSE:SUVEN)
317.00
-23.45 (-6.89%)
Jul 22, 2026, 3:30 PM IST
Suven Life Sciences Employees
Suven Life Sciences had 138 employees as of March 31, 2025. The number of employees decreased by 3 or -2.13% compared to the previous year.
Employees
138
Change (1Y)
-3
Growth (1Y)
-2.13%
Revenue / Employee
515.56K INR
Profits / Employee
-20.02M INR
Market Cap
89.86B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 138 | -3 | -2.13% |
| Mar 31, 2024 | 141 | 10 | 7.63% |
| Mar 31, 2023 | 131 | 14 | 11.97% |
| Mar 31, 2022 | 117 | -13 | -10.00% |
| Mar 31, 2021 | 130 | -12 | -8.45% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 17,244 |
| Akums Drugs and Pharmaceuticals | 7,337 |
| Strides Pharma Science | 3,301 |
| Alivus Life Sciences | 2,203 |
| Aarti Pharmalabs | 2,162 |
| RPG Life Sciences | 1,366 |
| Cohance Lifesciences | 1,212 |
| Orchid Pharma | 736 |
Suven Life Sciences News
- 14 days ago - Suven Life Sciences allots 1.85 crore shares on preferential basis for Rs 248.84 crore - Business Upturn
- 14 days ago - Suven Life Sciences raises ₹248.84 crore through preferential allotment - Business Upturn
- 4 weeks ago - Suven Life Sciences to showcase CNS clinical candidates at BIO-2026 in San Diego - Business Upturn
- 5 weeks ago - Suven Life Sciences reports positive results from Ropanicant Phase-2b trial for depression - Business Upturn
- 5 weeks ago - Suven Life Sciences successfully completes Phase-1 Clinical Trial of SUVN-I6107 for CNS disorders - Business Upturn
- 5 weeks ago - Suven Life Sciences to present Phase-3 narcolepsy study at SLEEP-2026 - Business Upturn
- 6 weeks ago - Suven Life Sciences reports positive DSMB review in Alzheimer's study - Business Upturn
- 2 months ago - Suven Life Sciences shares rally over 17% today; Details here - Business Upturn